You are here

Sanofi to market new haemophilia drug in deal with Alnylam

Paris

FRENCH pharmaceutical group Sanofi said it has obtained the right to develop and sell a new haemophilia drug in a restructuring of its partnership with Alnylam Pharmaceuticals.

Under the agreement, Sanofi will obtain global development and commercialisation rights to...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes